InMed Pharmaceuticals (TSX:IN) Accumulated other comprehensive income (loss) : C$0.17 Mil (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is InMed Pharmaceuticals Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. InMed Pharmaceuticals's Accumulated other comprehensive income (loss) for the quarter that ended in Dec. 2023 was C$0.17 Mil.

InMed Pharmaceuticals's quarterly Accumulated other comprehensive income (loss) increased from Jun. 2023 (C$0.17 Mil) to Sep. 2023 (C$0.18 Mil) but then declined from Sep. 2023 (C$0.18 Mil) to Dec. 2023 (C$0.17 Mil).

InMed Pharmaceuticals's annual Accumulated other comprehensive income (loss) increased from Jun. 2021 (C$0.16 Mil) to Jun. 2022 (C$0.17 Mil) and increased from Jun. 2022 (C$0.17 Mil) to Jun. 2023 (C$0.17 Mil).

InMed Pharmaceuticals Accumulated other comprehensive income (loss) Historical Data

The historical data trend for InMed Pharmaceuticals's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InMed Pharmaceuticals Accumulated other comprehensive income (loss) Chart

InMed Pharmaceuticals Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Accumulated other comprehensive income (loss)

Get a 7-Day Free Trial

-0.41

0.16

0.17

InMed Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accumulated other comprehensive income (loss)	Get a 7-Day Free Trial															0.18	0.18	0.17	0.18	0.17

InMed Pharmaceuticals Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

InMed Pharmaceuticals Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of InMed Pharmaceuticals's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

InMed Pharmaceuticals (TSX:IN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InMed Pharmaceuticals Inc (TSX:IN) » Definitions » Accumulated other comprehensive income (loss)

Comparable Companies

Traded in Other Exchanges

INM:USA MWG0:Germany

Address

815 West Hastings Street, Suite 310, Vancouver, BC, CAN, V6C 1B4

Website

https://www.inmedpharma.com

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

InMed Pharmaceuticals (TSX:IN) Headlines

No Headlines